These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 10573512)

  • 1. Cognitive impairment in alcoholic and nonalcoholic cirrhotic patients.
    Edwin D; Flynn L; Klein A; Thuluvath PJ
    Hepatology; 1999 Dec; 30(6):1363-7. PubMed ID: 10573512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of motor and cognitive deficits in detoxified alcoholic men.
    Sullivan EV; Rosenbloom MJ; Pfefferbaum A
    Alcohol Clin Exp Res; 2000 May; 24(5):611-21. PubMed ID: 10832902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a three-factor neuropsychological approach for detecting minimal hepatic encephalopathy.
    Stewart CA; Enders FT; Schneider N; Felmlee-Devine D; Kamath PS; Smith GE
    Liver Int; 2010 Jul; 30(6):841-9. PubMed ID: 20412441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isokinetic muscle strength and its association with neuropsychological capacity in cirrhotic alcoholics.
    Tarter RE; Panzak G; Switala J; Lu S; Simkevitz H; Van Thiel D
    Alcohol Clin Exp Res; 1997 Apr; 21(2):191-6. PubMed ID: 9113251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychomotor performance defects in cirrhotic patients without overt encephalopathy.
    Gilberstadt SJ; Gilberstadt H; Zieve L; Buegel B; Collier RO; McClain CJ
    Arch Intern Med; 1980 Apr; 140(4):519-21. PubMed ID: 7362383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological function in Greek patients with chronic hepatitis C.
    Karaivazoglou K; Assimakopoulos K; Thomopoulos K; Theocharis G; Messinis L; Sakellaropoulos G; Labropoulou-Karatza C
    Liver Int; 2007 Aug; 27(6):798-805. PubMed ID: 17617123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests.
    Amodio P; Del Piccolo F; Marchetti P; Angeli P; Iemmolo R; Caregaro L; Merkel C; Gerunda G; Gatta A
    Hepatology; 1999 Jun; 29(6):1662-7. PubMed ID: 10347105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial infection in cirrhotic patients and its relationship with alcohol.
    Rosa H; Silvério AO; Perini RF; Arruda CB
    Am J Gastroenterol; 2000 May; 95(5):1290-3. PubMed ID: 10811341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and patterns of cognitive impairment in sporadic ALS.
    Ringholz GM; Appel SH; Bradshaw M; Cooke NA; Mosnik DM; Schulz PE
    Neurology; 2005 Aug; 65(4):586-90. PubMed ID: 16116120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive functions in patients with liver cirrhosis: assessment using community screening interview for dementia.
    Adekanle O; Sunmonu TA; Komolafe MA; Ndububa DA
    Ann Afr Med; 2012; 11(4):222-9. PubMed ID: 23103921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C.
    Hilsabeck RC; Hassanein TI; Carlson MD; Ziegler EA; Perry W
    J Int Neuropsychol Soc; 2003 Sep; 9(6):847-54. PubMed ID: 14632243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of Apo E and ACE genes to cognitive performance in chronic alcoholic patients.
    Bartrés-Faz D; Clemente IC; Monràs M; Muñoz M; López-Alomar A; Valveny N; Moral P; Gual A; Sánchez-Turet M; Guardia J; Junqué C
    Addict Biol; 2002 Apr; 7(2):227-33. PubMed ID: 12006218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and nutritional status in alcohol addicts and patients with chronic liver disease.
    Panagaria N; Varma K; Nijhawan S; Mathur A; Rai RR
    Trop Gastroenterol; 2007; 28(4):171-5. PubMed ID: 18416348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological impairment in patients with chronic hepatitis C.
    Hilsabeck RC; Perry W; Hassanein TI
    Hepatology; 2002 Feb; 35(2):440-6. PubMed ID: 11826421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortisol dysregulation and cognitive impairment in abstinent male alcoholics.
    Errico AL; King AC; Lovallo WR; Parsons OA
    Alcohol Clin Exp Res; 2002 Aug; 26(8):1198-204. PubMed ID: 12198394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment in people diagnosed with end-stage liver disease evaluated for liver transplantation.
    Sorrell JH; Zolnikov BJ; Sharma A; Jinnai I
    Psychiatry Clin Neurosci; 2006 Apr; 60(2):174-81. PubMed ID: 16594941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological impairment in deficit vs. non-deficit schizophrenia.
    Cascella NG; Testa SM; Meyer SM; Rao VA; Diaz-Asper CM; Pearlson GD; Schretlen DJ
    J Psychiatr Res; 2008 Sep; 42(11):930-7. PubMed ID: 18021807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment in Behçet's disease patients without overt neurological involvement.
    Monastero R; Camarda C; Pipia C; Lopez G; Camarda LK; Baiamonte V; Ferrante A; Triolo G; Camarda R
    J Neurol Sci; 2004 May; 220(1-2):99-104. PubMed ID: 15140614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.